{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:33:54Z","timestamp":1791178434443,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1136\/ard.2007.075523","type":"journal-article","created":{"date-parts":[[2007,9,4]],"date-time":"2007-09-04T00:26:14Z","timestamp":1188865574000},"page":"614-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study"],"prefix":"10.1016","volume":"67","author":[{"given":"L","family":"Sailler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Arlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Arlet-Suau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Uro-Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Adoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Fournie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Zabraniecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Cintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.075523_bib1","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1001\/archinte.165.22.2671","article-title":"Outcomes in 45 patients with statin-associated myopathy","volume":"165","author":"Hansen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2007.075523_bib2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/mus.20127","article-title":"Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake","volume":"30","author":"Vasconcelos","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1136\/ard.2007.075523_bib3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0151-9638(05)79565-X","article-title":"Fluvastatin-induced dermatomyositis","volume":"132","author":"Thual","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1136\/ard.2007.075523_bib4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.revmed.2005.07.005","article-title":"Pravastatin-induced dermatomyositis","volume":"26","author":"Zuech","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1136\/ard.2007.075523_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJM199208273270919","article-title":"Pravastatin-associated inflammatory myopathy","volume":"327","author":"Schalke","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2007.075523_bib6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/pgmj.72.853.694","article-title":"Lovastatin-associated dermatomyositis","volume":"72","author":"Rodriguez-Garcia","year":"1996","journal-title":"Postgrad Med J"},{"key":"10.1136\/ard.2007.075523_bib7","first-page":"934","article-title":"Severe polymyositis with simvastatin use","volume":"37","author":"Riesco-Eizaguirre","year":"2003","journal-title":"Rev Neurol"},{"key":"10.1136\/ard.2007.075523_bib8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.revmed.2003.10.013","article-title":"Polymyositis induced or associated with lipid-lowering drugs: five cases","volume":"25","author":"Fauchais","year":"2004","journal-title":"Rev Med Interne"},{"key":"10.1136\/ard.2007.075523_bib9","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(05)61628-5","article-title":"Polymyositis associated with simvastatin","volume":"349","author":"Giordano","year":"1997","journal-title":"Lancet"},{"key":"10.1136\/ard.2007.075523_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1445-5994.1995.tb02870.x","article-title":"Dermatomyositis with lung involvement in a patient treated with simvastatin","volume":"25","author":"Hill","year":"1995","journal-title":"Aust N Z J Med"},{"key":"10.1136\/ard.2007.075523_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/rheumatology\/33.2.199","article-title":"Simvastatin-associated dermatomyositis","volume":"33","author":"Khattak","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2007.075523_bib12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9343(01)00711-2","article-title":"Atorvastatin-induced dermatomyositis","volume":"110","author":"Noel","year":"2001","journal-title":"Am J Med"},{"key":"10.1136\/ard.2007.075523_bib13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archinte.166.14.1519","article-title":"Presymptomatic neuromuscular disorders disclosed following statin treatment","volume":"166","author":"Tsivgoulis","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2007.075523_bib14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1258\/000456303322326542","article-title":"The case of stainless statins","volume":"40","author":"Barth","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1136\/ard.2007.075523_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1258\/0004563041201554","article-title":"McArdle's disease diagnosed following statin-induced myositis","volume":"41","author":"Livingstone","year":"2004","journal-title":"Ann Clin Biochem"},{"key":"10.1136\/ard.2007.075523_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.revmed.2005.08.012","article-title":"Dilated cardiomyopathy and lipid-lowering drug muscle toxicity revealing late-onset Becker's disease","volume":"26","author":"Vandenhende","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1136\/ard.2007.075523_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2796.2005.01515.x","article-title":"Statin-disclosed acid maltase deficiency","volume":"258","author":"Voermans","year":"2005","journal-title":"J Intern Med"},{"key":"10.1136\/ard.2007.075523_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199905000-00001","article-title":"Influence of age on characteristics of polymyositis and dermatomyositis in adults","volume":"78","author":"Marie","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard.2007.075523_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1136\/ard.2007.075523_bib20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","article-title":"Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria","volume":"28","author":"Mastaglia","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.2007.075523_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00228-006-0131-1","article-title":"Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?","volume":"62","author":"Clark","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1136\/ard.2007.075523_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ahj.2005.08.023","article-title":"A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention","volume":"152","author":"Brophy","year":"2006","journal-title":"Am Heart J"},{"key":"10.1136\/ard.2007.075523_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00228-004-0760-1","article-title":"Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals","volume":"60","author":"Dugu\u00e9","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1136\/ard.2007.075523_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/mus.10016","article-title":"Bent spine syndrome: computed tomographic study and isokinetic evaluation","volume":"25","author":"Laroche","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1136\/ard.2007.075523_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mus.20567","article-title":"Genetic risk factors associated with lipid-lowering drug-induced myopathies","volume":"34","author":"Vladutiu","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1136\/ard.2007.075523_bib26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/pds.1287","article-title":"Risk factors for statin-associated rhabdomyolysis","volume":"16","author":"Schech","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1136\/ard.2007.075523_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1086\/507132","article-title":"Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers","volume":"79","author":"Bua","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard.2007.075523_bib28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.clpt.6100124","article-title":"Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin","volume":"81","author":"Schick","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1136\/ard.2007.075523_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","article-title":"Progressive myopathy with up-regulation of MHC-I associated with statin therapy","volume":"17","author":"Needham","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1136\/ard.2007.075523_bib30","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1073\/pnas.0508492103","article-title":"Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells","volume":"103","author":"Arora","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2007.075523_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"key":"10.1136\/ard.2007.075523_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20051129","article-title":"Isoprenoids determine Th1\/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin","volume":"203","author":"Dunn","year":"2006","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2007.075523_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"61","author":"van der Meulen","year":"2003","journal-title":"Neurology"},{"key":"10.1136\/ard.2007.075523_bib34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2125.2006.02609.x","article-title":"The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention","volume":"61","author":"Mangoni","year":"2006","journal-title":"Br J Clin Pharmacol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724218008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724218008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.075523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T15:38:46Z","timestamp":1736091526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724218008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0003496724218008"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.075523","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.075523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}